Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Stanford University1,000 enrolled

Overview

The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma virus (HPV). For this study, the investigators plan to collect blood from OPC patients prior to treatment and at six subsequent time points.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Oropharyngeal Carcinoma Human Papilloma Virus

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with oropharyngeal carcinoma or patients with cancer of the unknown primary that is HPV associated, or possibly deemed to be originating from the oropharynx. Exclusion Criteria: * Not willing to sign consent

Locations (1)

Stanford University

Palo Alto, California, United States

RECRUITING

Outcomes

Primary Outcomes

Sample collection

30-50cc of blood

Time frame: prior to start of treatment

Sample collection

30-50cc of blood

Time frame: up to 36 months post-op

Secondary Outcomes

tumor sample

tumor sample (FFPE) or fresh tissue post-excision or surgery, this will only be collected, if and when feasible, after the tumor has been removed post procedure.

Time frame: Day 1

Central Contacts

Nikita Bedi

CONTACT

(650) 723-5957 nbedi@stanford.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.